BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM TOX

File: 123096_sep96_decls58_0009.txt
Page: 0009
Total Pages: 9

Subject: BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM TOX    

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM                                               

Document Number:          1

Folder Seq  #:        226



                                       UNCLASSIFIED





          3. Expectant anthrax and botulinum patients

              a. Anthrax patients who have developed symptoms are
          expectant. Death occurs approximately 2-8 days after exposure to a
          lethal dose. Supportive therapy is recommended. Stress management
          and Chaplain support are encouraged for staff as well as patients.

              b. Although botulinum patients can be treated with the
          antitoxin, there are limited supplies. A number of botulinum
          patients will not receive the antitoxin. Provide supportive
          therapy within the medical treatment facility's capability. Stress
          management and Chaplain support are encouraged for staff as well as
          patients.

          4. Management of potentially anthrax exposed patients with
          conventional injuries before appearance of anthrax symptoms (i.e.,
          surgery, taking blood samples, handling of blood samples in the lab
          and disposal, starting I.V.s by staff, precautions, periodic
          testing with the anthrax diagnostic kit, recommendations, course of
          action if anthrax symptoms appear and/or positive test on anthrax
          diagnostic kit, etc).

          5. Management of botulinum patients with conventional injuries.
          The greatest concern is that patient decontamination is thorough
          with 0.5 Percent hvdochlorite solution.
          I
          against botulinum toxin needs to be explored. management and
          treatment of the botulinum patients should be no different than any
          other patient once decontamination is complete.











          7. Handling of Patient Remains

              a. Confirmed anthrax victim - Care should be taken in handling
          of body fluids. Remains should be properly marked before burial
          and

              b. Confirmed botulinum victim - Handle as anyother patient.
nto the medical
          treatment facility.

                                            3


                                       UNCLASSIFIED

Document 9 f:/Week-36/BX003203/BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM/biological warfare defense against anthrax and b:12179609290159
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BIO WARFARE DEFENSE AGAINST ANTHRAX AND BOTULINUM
Folder Seq # = 226
Subject = BIOLOGICAL WARFARE DEFENSE AGAINST ANTHRAX AND B
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996